BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36156129)

  • 1. Identification of patient subgroups with low risk of postoperative local recurrence for whom total mesorectal excision surgery alone is sufficient: a multicenter retrospective analysis.
    Yamamoto T; Kawada K; Matsusue R; Kato S; Itatani Y; Hida K; Machimoto T; Yamaguchi T; Obama K
    Int J Colorectal Dis; 2022 Oct; 37(10):2207-2218. PubMed ID: 36156129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal treatment strategy for rectal cancer based on the risk factors for recurrence patterns.
    Yamamoto T; Kawada K; Hida K; Ganeko R; Inamoto S; Yoshitomi M; Watanabe T; Sakai Y
    Int J Clin Oncol; 2019 Jun; 24(6):677-685. PubMed ID: 30721379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy.
    Ogura A; Akiyoshi T; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M; Kuroyanagi H
    World J Surg; 2017 Mar; 41(3):868-875. PubMed ID: 27730352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
    Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
    Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
    Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
    World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer.
    Akiyoshi T; Matsueda K; Hiratsuka M; Unno T; Nagata J; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S614-20. PubMed ID: 25896145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of lateral pelvic lymph node recurrences in rectal cancer: a radiation oncologist's perspective.
    Choi SH; Chang JS; Yoon HI; Jang DS; Kim NK; Lim JS; Min BS; Huh H; Shin SJ; Ahn JB; Koom WS
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1119-1128. PubMed ID: 29546480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does adding lateral pelvic lymph node dissection to neoadjuvant chemotherapy improve outcomes in low rectal cancer?
    Law BZY; Yusuf Z; Ng YE; Aly EH
    Int J Colorectal Dis; 2020 Aug; 35(8):1387-1395. PubMed ID: 32504333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with lateral pelvic recurrence after curative resection following neoadjuvant chemoradiotherapy in rectal cancer patients.
    Kim TG; Park W; Choi DH; Park HC; Kim SH; Cho YB; Yun SH; Kim HC; Lee WY; Lee J; Park JO; Park YS; Lim HY; Kang WK; Chun HK
    Int J Colorectal Dis; 2014 Feb; 29(2):193-200. PubMed ID: 24322736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative lateral lymph node features and impact on local recurrence after neoadjuvant chemoradiotherapy and total mesorectal excision for locally advanced rectal cancer: results from a multicentre international cohort study.
    Achilli P; Ferrari D; Calini G; Bertoglio CL; Magistro C; Origi M; Carnevali P; Alampi BD; Giusti I; Ferrari G; Calafiore E; Spinelli A; Grass F; Deslarzes P; Hahnloser D; Abdalla S; Larson DW
    Colorectal Dis; 2024 Mar; 26(3):466-475. PubMed ID: 38243617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lateral pelvic lymph node metastasis in T2 low rectal cancer: is TME alone sufficient for cure?
    Ouchi A; Inoue M; Sato Y; Takamizawa Y; Kinoshita T; Moritani K; Komori K; Tsukamoto S; Shimizu Y; Kanemitsu Y
    Jpn J Clin Oncol; 2023 Apr; 53(5):386-392. PubMed ID: 36722355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease?
    Akiyoshi T; Watanabe T; Miyata S; Kotake K; Muto T; Sugihara K;
    Ann Surg; 2012 Jun; 255(6):1129-34. PubMed ID: 22549752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation?
    Malakorn S; Yang Y; Bednarski BK; Kaur H; You YN; Holliday EB; Dasari A; Skibber JM; Rodriguez-Bigas MA; Chang GJ
    Dis Colon Rectum; 2019 Oct; 62(10):1158-1166. PubMed ID: 31490825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomics Approach Outperforms Diameter Criteria for Predicting Pathological Lateral Lymph Node Metastasis After Neoadjuvant (Chemo)Radiotherapy in Advanced Low Rectal Cancer.
    Nakanishi R; Akiyoshi T; Toda S; Murakami Y; Taguchi S; Oba K; Hanaoka Y; Nagasaki T; Yamaguchi T; Konishi T; Matoba S; Ueno M; Fukunaga Y; Kuroyanagi H
    Ann Surg Oncol; 2020 Oct; 27(11):4273-4283. PubMed ID: 32767224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and prognostic significance of lateral pelvic lymph node metastasis in advanced rectal cancer.
    Hiyoshi Y; Miyamoto Y; Kiyozumi Y; Eto K; Nagai Y; Iwatsuki M; Iwagami S; Baba Y; Yoshida N; Baba H
    Int J Clin Oncol; 2020 Jan; 25(1):110-117. PubMed ID: 31407167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploratory analysis of lateral pelvic sentinel lymph node status for optimal management of laparoscopic lateral lymph node dissection in advanced lower rectal cancer without suspected lateral lymph node metastasis.
    Yasui M; Ohue M; Noura S; Miyoshi N; Takahashi Y; Matsuda C; Nishimura J; Haraguchi N; Ushigome H; Nakai N; Fujino S; Sugimura K; Wada H; Takahashi H; Omori T; Miyata H
    BMC Cancer; 2021 Aug; 21(1):911. PubMed ID: 34380428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically enlarged lateral pelvic lymph nodes do not influence prognosis after neoadjuvant therapy and TME in stage III rectal cancer.
    Dharmarajan S; Shuai D; Fajardo AD; Birnbaum EH; Hunt SR; Mutch MG; Fleshman JW; Lin AY
    J Gastrointest Surg; 2011 Aug; 15(8):1368-74. PubMed ID: 21533959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lateral Pelvic Lymph Node Metastases in Rectal Cancer: A Systematic Review.
    Atef Y; Koedam TW; van Oostendorp SE; Bonjer HJ; Wijsmuller AR; Tuynman JB
    World J Surg; 2019 Dec; 43(12):3198-3206. PubMed ID: 31468119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A single center retrospective study on surgical efficacy of T3NxM0 middle-low rectal cancer without neoadjuvant therapy].
    Liu P; Lou Z; Mei Z; Gao X; Hao L; Liu L; Gong H; Meng R; Yu E; Wang H; Wang H; Zhang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):66-72. PubMed ID: 30703796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant Chemoradiotherapy Prior to Lateral Lymph Node Dissection in Rectal Cancer with Suspected Lateral Lymph Node Metastasis: a Multicenter Lateral Node Study in China.
    Zhou S; Song Y; Xie Y; Liu Q
    J Gastrointest Surg; 2023 Jan; 27(1):158-161. PubMed ID: 35882759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.